Cancer Pharmacology - MSc

Postgraduate

In London

Price on request

Description

  • Type

    Postgraduate

  • Location

    London

  • Duration

    1 Year

With worldwide cancer rates increasing and expected to reach 22 million new cases per year by 2030, this postgraduate course introduces you to how radiotherapy, surgery and chemotherapy have a vital role to play in prolonging the lives of patients.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving. You’ll also review the biology of cancer with respect to genetics, pathological considerations and the molecular changes within cells which are associated with the progression of the disease.

You'll be taught by staff who are experienced researchers in areas such as cancer biology, immunology, genetics and bioinformatics. They will help you learn how to collect, analyse, interpret and understand scientific data you must make use of in the cancer pharmacology field. This ensures you’ll not only improve your intellectual knowledge but your practical skills as well.

Your laboratory-based project will be conducted in our £30 million Science Centre. This includes access to extensive cell culture facilities, electrophoresis equipment, polymerase chain reaction (PCR) cyclers and high performance liquid chromatography (HPLC) instrumentation.

Overall, this programme of advanced study provides you with the necessary skills, knowledge and understanding for you to pursue a career in anti-cancer drug development.

Facilities

Location

Start date

London
See map
31 Jewry Street, EC3N 2EY

Start date

On request

About this course

London Met’s Cancer Pharmacology master's course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.



at least a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis)

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Fill in your details to get a reply

We will only publish your name and question

Reviews

Subjects

  • Pharmacology
  • IT
  • Bioinformatics
  • Project
  • Genetics
  • Biology
  • Cancer Pharmacology
  • Therapy
  • Diagnosis and Therapy
  • Cancer
  • Medical Genetics

Course programme

Modular structure
  • The modules listed below are for the academic year 2020/21 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.
Year 1 modules include:
  • Cancer Pharmacology (core, 20 credits)
  • Cancer: Diagnosis and Therapy (core, 20 credits)
  • Medical Genetics and Genomics (core, 20 credits)
  • Molecular Oncology (core, 20 credits)
  • Research Project (core, 60 credits)
  • Scientific Frameworks For Research (core, 20 credits)
  • Advanced Drug Formulation Technologies (option, 20 credits)
  • Bioinformatics and Molecular Modelling (option, 20 credits)
  • Drug Discovery Technology (option, 20 credits)
Assessment
  • Assessment on this master's course is completed through a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Cancer Pharmacology - MSc

Price on request